A powerful digestive supplement and group of B-vitamins treat digestive disorders. Promotes the digestion of starch, carbohydrates, fats, and proteins found in ingested food. Significantly accelerates the rate of digestion and helps to restore the loss of appetite. Eases digestive symptoms such as acid indigestion, flatulence, epigastric distress, burping dyspepsia, and heartburn. Aids in proper digestion by accelerating the digestion process and gastric problems in the body. Assists in boosting the immune system, and prevents vitamin deficiency due to poor diet, chronic illness. A beneficial digestive aid for loss of appetite due to chronic illness, stomach fullness, and indigestion. Protects the mucous membranes in the digestive system. Helps maintain a healthy digestive system and regulates appetite.

A broad range of antibiotics helps in fighting various types of bacteria. (N J Leggett, 1990) Has an extended spectrum of antibacterial activity inhibiting beta-lactamase-producing respiratory pathogens. (H C Neu, 1993) The drug of choice for the treatment of respiratory tract infections. Inhibits the majority of pathogens, 90%, of Streptococcus pneumoniae, Streptococcus pyogenes, Branhamella catarrhalis, Haemophilus influenzae, Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis. (Neu, 1987) Effective treatment for pneumonia and acute bacterial exacerbations of bronchitis. (H C Neu, 1993) Better at both eradicating and preventing recurrences of group A streptococcus bacteria compared with penicillin V. (Ben JK Tan, 1995) Offers the additional benefit of covering beta-lactamase-producing strains of bacteria that are resistant to many penicillins. (D R Edelstein, 1993) A useful therapeutic option for the treatment of urinary tract infection with a success rate comparable to that of trimethoprim-sulfamethoxazole. (Ben JK Tan, 1995) Exhibits good activity against most pathogens causing urinary tract infections. (Modai, 1989) A suitable alternative to cefaclor or amoxicillin in acute otitis media, acute upper and lower respiratory tract infections. (R N Brogden, 1989)

A broad-spectrum antimicrobial agent against a variety of gram-positive and -negative bacteria. (N J Leggett, 1990) A useful cephalosporin for the treatment of bacterial infections in children. (T Hosoda, 1986) Possesses excellent efficacy against a broad spectrum of pathogens, including Haemophilus influenzae, Streptococcus pneumoniae, and Moraxella catarrhalis. (Adam, 1998) Offers an additional benefit of covering beta-lactamase-producing strains of bacteria which are resistant to many penicillins. (D R Edelstein, 1993) An effective treatment for mild to moderate lower respiratory tract infection. (A Markham, 1995) A viable alternative to amoxicillin for infants and children with acute otitis media. (Bluestone, 1993) An effective candidate for the treatment of urinary tract infection. (Ben JK Tan, 1995)

A combination of penicillin-class antibacterial and beta-lactamase inhibitors that treats a wide variety of bacterial infections by stopping the growth of bacteria. A potent broad spectrum of antibacterial activity against aerobic and anaerobic, including beta-lactamase-producing pathogens. (Anthony R White, 2004) The first-line therapy for uncomplicated acute otitis media, sinusitis, and pneumonia because of its activity against Streptococcus pneumoniae and Haemophilus influenza. (Klein, 2003) Exerts high bacteriological and clinical efficacy in respiratory tract infection over more than 20 years. (Anthony R White C. K., 2004) Eradicates or suppresses all penicillin-susceptible and penicillin-intermediate Streptococcus pneumoniae and 73% of penicillin-resistant Streptococcus pneumoniae. (Klein J. O., 2003) An effective drug for a variety of pediatric infectious diseases, including acute otitis media, sinusitis, pneumonia, urinary tract infections, and infections of the skin and soft tissues. (Klein J. O., 2003) Has comparable efficacy to cefaclor for treating uncomplicated urinary tract infections, acute bronchitis, bronchopneumonia, acute sinusitis, otitis media, and skin and soft-tissue infections. (G E Stein, 1984)

A synthetic anabolic steroid that effectively treats osteoporosis in postmenopausal women. (Federico Giuseppe Patanè, 2020) Increases bone density by stimulating bone formation. (L P Schot, 1993) Induces an increase in bone mass and prevents further losses in patients with corticosteroid-induced osteoporosis. (S Adami, 1993) Has an anti-inflammatory effect on joints and promotes joint healing. Increases the bone formation rate through inhibition of bone resorption. (C Gennari, 1989) Alleviates bone pain in postmenopausal osteoporosis patients. (Alexander J. Tatem, 2020) Diminishes vertebral pain and increases the mobility of the spine. (Geusens, 1995) A convenient strategy for the prevention and treatment of corticosteroid-induced osteoporosis. (S Adami, 1993) Demonstrates a significant rise in forearm bone mineral content in postmenopausal women with osteoporosis. (A G Need, 1987)

The most effective analogue of vitamin B12 treats or prevents the complications associated with vitamin B12 deficiency. (Amrita Sil, 2018) Aids in the growth of healthy blood cells, nerve cells, red blood cell formation, and DNA synthesis. (Amrita Sil H. K., 2018) Beneficial drug for most of the common disorders like cardiovascular disorders, diabetes, anemia, hyperhomocysteinemia and degenerative disorders. (Gupta JK and Qureshi Shaiba Sana, 2015) Exerts neuronal protection by promoting regeneration to injured nerves. (Gupta JK and Qureshi Shaiba Sana, 2015) A promising dietary supplement and the best treatment for people who cannot absorb vitamin B12 and suffers from its deficiencies. (Gupta JK and Qureshi Shaiba Sana, 2015) An effective treatment for patients with pernicious anemia as it promptly corrects the hematological and neurological abnormalities. (Yumi Takasaki, 2002) A suitable alternative to cyanocobalamin /hydroxocobalamin in the treatment of vitamin B12 deficiency. (Ashwin Kamath, 2017)

A broad-spectrum antibiotic effective against both gram-positive and gram-negative bacteria. A promising candidate for the therapy of urinary tract infections. (Demetra Kavatha, 2003) An effective and safe drug as trimethoprim-sulfamethoxazole for the treatment of acute uncomplicated lower urinary tract infections. (Demetra Kavatha H. G., 2003) A useful alternative to fluoroquinolones for the treatment of cystitis with its broad spectrum of antimicrobial activity. (Thomas M. Hooton, 2013) Proved to be as effective as cefaclor or amoxicillin, with no significant differences in the clinical cure rates (79, 79, and 72%, respectively) or in the bacteriological eradication rates (80, 82, and 70%, respectively). (Demetra Kavatha H. G., 2003) Has proven efficacy in the treatment of community-acquired pneumonia and upper respiratory tract, skin and soft tissue, and urinary tract infections. (J A Balfour, 1996) As effective as amoxicillin/clavulanic acid in treating either acute otitis media or sinusitis. (J A Balfour, 1996) More effective than phenoxymethyl-penicillin in the treatment of pharyngotonsillitis.(J A Balfour, 1996) A useful addition to the antibacterial available for the treatment of infections of the lower respiratory tract. (A M Geddes, 1991)

A broad-spectrum antibiotic that has good antimicrobial activity against aerobic gram-positive and gram-negative bacteria. (Arijit Ghosh, 2012) Clavulanic Acid is a beta-lactamase inhibitor which reduces resistance and enhances the activity of Cefpodoxime against bacteria. An effective antibiotic for the treatment of acute exacerbations of chronic bronchitis. (P Periti, 1990) Exerts higher cure rates (95.6%) compared with other oral third-generation cephalosporins. (Arijit Ghosh, 2012) A valuable addition to the antibacterial available for the treatment of infections of the lower respiratory tract. (A M Geddes, 1991) Has potent antibacterial activity against the major bacterial pathogens involved in lower respiratory tract infections. (Geddes, 1991) A safe and useful agent in the therapy of skin and soft tissue infections. (K J Tack, 1991) A better-tolerated medicine that is associated with better compliance than penicillin-based regimens. (J A Balfour P. B., 1996)

A broad range of antibiotics helps in fighting various types of bacteria. (N J Leggett, 1990) Has an extended spectrum of antibacterial activity inhibiting beta-lactamase-producing respiratory pathogens. (H C Neu, 1993) The drug of choice for the treatment of respiratory tract infections. Inhibits the majority of pathogens, 90%, of Streptococcus pneumoniae, Streptococcus pyogenes, Branhamella catarrhalis, Haemophilus influenzae, Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis. (Neu, 1987) Effective treatment for pneumonia and acute bacterial exacerbations of bronchitis. (H C Neu, 1993) Better at both eradicating and preventing recurrences of group A streptococcus bacteria compared with penicillin V. (Ben JK Tan, 1995) Offers the additional benefit of covering beta-lactamase-producing strains of bacteria that are resistant to many penicillins. (D R Edelstein, 1993) A useful therapeutic option for the treatment of urinary tract infection with a success rate comparable to that of trimethoprim-sulfamethoxazole. (Ben JK Tan, 1995) Exhibits good activity against most pathogens causing urinary tract infections. (Modai, 1989) A suitable alternative to cefaclor or amoxicillin in acute otitis media, acute upper and lower respiratory tract infections. (R N Brogden, 1989)

Belongs to a group of medicines called anti-anemic agents that replenishes the iron stores in the body. Significantly increases ferritin and hemoglobin concentrations and efficiently raises the iron stores. A well-tolerated, high compliance agent and more efficiently increases hemoglobin levels in iron-deficient anemic pregnant women than ferrous glycine sulfate. (Ahmed M Abbas, 2019) Shows a rapid rate of hemoglobin synthesis. (Ching-Tzu Lee, 2016) An effective alternative treatment in patients with iron deficiency anemia. A safe and effective treatment option for iron deficiency and anemia. Improves overall zinc status better than other zinc supplements. Restores B12 levels in the body and prevents the complications associated with vitamin B12 deficiency. Helps in treating certain anemias and nerve problems. A useful therapeutic agent for the production of red blood cells and treats megaloblastic anemia caused by vitamin B12 deficiency. Provides a higher increase in hemoglobin level (2.48 g/dL) than ferrous glycine sulfate (1.32g/dL). (Ahmed M Abbas S. A., 2019)

A unique formulation of proteolytic enzymes, bioflavonoid, NSAID that soothes inflammation and promotes faster wound healing. Raises the blood flow to the area of injury, helps the body to produce substances that fight pain and swelling. A promising new treatment that relieves pain and shows significant improvement in functionality in patients with osteoarthritis. Possesses analgesic, anti-inflammatory, anti-edematous and antioxidant properties. (Khobre, 2017) Provides highly significant reductions in pain, improves chewing ability, mouth opening, joint noise, and jerky mandibular movement in the temporomandibular joint osteoarthritis population. (Prashant Gupta, 2020) Relieves pain and inflammation due to trauma, surgery. A highly significant reduction in pain with faster chewing ability than diclofenac 50mg. (Prashant Gupta, 2020) Shows significant improvement in reducing pain in patients with temporomandibular osteoarthritis. (S Jayachandran, 2017) A safe and effective option for the management of joint pain.

A class of medications called penicillin-like antibiotics is used to treat infections caused by bacteria in different parts of the body. A penicillin derivative that has activity against both gram-positive and gram-negative bacteria. (Justin Evans) Exerts a bactericidal action against both Gram-positive and Gram-negative microorganisms by inhibiting the biosynthesis and repair of the bacterial cell wall. A promising agent for bacterial infections, such as chest infections (including pneumonia) and dental abscesses. A first-choice medicine to treat many bacterial infections. An effective antibiotic treatment for exacerbations of chronic bronchitis and chronic obstructive pulmonary disease. (Carl Llor, 2009)

A combination medicine of bronchodilator, mucolytic, and expectorant is used in the treatment of cough with mucus. Soothes the throat irritation and relieves cough. Provides relief from runny nose, sneezing, itching, and watery eyes. Decreases the sputum's thickness and helps to it cough out easily. Clears congestion and enables easy breathing. Prevent and treat the symptoms of asthma and chronic obstructive pulmonary disease.

A perfect combination that provides instant relief from the common cold, flu, fever, cough, and allergies. Eases the symptoms of colds and flu, hay fever, and respiratory allergies. Works by thinning and loosening mucus in the airways, clearing congestion, and making breathing easier. An effective nasal decongestant that narrows the small blood vessels providing relief from congestion or stuffiness in the nose. Decreases activity in the part of the brain that causes coughing. The most widely used antitussives for the treatment of cough associated with acute upper respiratory tract infection. (Lee PCL, 2000) Blocks the histamine action which reduces allergic symptoms and gives relief from allergic signs such as watery eyes, runny nose, and sneezing. Produces analgesia by blocking chemical messengers in the brain that causes A highly efficacious drug for the treatment of allergic diseases, such as allergic rhinitis and chronic idiopathic urticaria in children. (J L Devalia, 2001) Reduces the symptoms of allergic rhinitis and improves the health-related quality of life in both seasonal allergic rhinitis and perennial allergic rhinitis. (Zhang L, 2013)

A combination tablet (analgesic, decongestant, and anti-histaminic) is used for the treatment of symptoms caused by cold, allergies, stuffy nose, headache, and fever. An effective antipyretic and analgesic drug to ameliorate pain and fever in cold and flu conditions. (G.G.G. de Oliveira, 2017) Provides more potent, faster onset, and quick relief from cold, fever, and body aches. Effectively relieves nasal discomfort in patients with allergic rhinitis. (Peter Small, 2018) Shows anti-allergic response by blocking histamine that is causing an allergic reaction such as sneezing, coughing, itching, running nose, and conjunctivitis. A safe agent that provides optimum symptomatic relief in allergic rhinitis patients. (Mayuresh Kiran, 2019) One of the most widely used drugs for the relief of mild to moderate pain. (Fathalla Belal, 2018) An effective nasal decongestant that narrows the small blood vessels providing relief from congestion or stuffiness in the nose.

A probiotic that treats intestinal microbial dysbiosis. (E. Ghelardi, 2015) Effectively restores the microflora symbiosis in the intestinal tract. (E. Ghelardi, 2015) Possesses probiotic properties that exert beneficial effects on human health. (Roberto Berni Canani, 2007) A safe probiotic strain that significantly decreases the duration and frequency of diarrhea in children. (M Ratna Sudha, 2019) Prevents and treats symptoms resulting from an unbalanced gut microbiome, such as diarrhea and abdominal pain. Effectively reduces the growth of harmful bacteria and stimulates the body's immune response. (Natallia V Varankovich, 2015) A safe and effective treatment in alleviating acute childhood diarrhea symptoms without causing any adverse effects. (Gianluca Ianiro, 2018) An effective probiotic that inhibits the growth of pathogens in the gastrointestinal tract, enhances digestive health. (M, 2015) Significantly reduces the number of stools on each day of treatment and improves stool consistency. (Jo-Anne A. de Castro, 2019) Lowers the incidences of nausea, diarrhea, and epigastric pain in patients treated with Bacillus clausii.

An antacids medication is used in the treatment of acidity, stomach ulcer, heartburn and alleviates pain associated with diseases of the stomach and intestines. A potent local anesthetic agent gives prompt and prolonged relief of pain associated with peptic ulcer disease or esophagitis. (Rajendra Kumar Parakh, 2018) A cytoprotective drug forms a protective barrier at the ulcer site and prevents several gastrointestinal diseases. (M Candelli, 2000) An effective drug for the treatment of gastric and duodenal ulcers owing to its protective gel-forming ability. (Takuya Hayakawa, 2019) Has the potential to protect the esophageal mucosa against reflux esophagitis. (Takuya Hayakawa, 2019) Promotes the healing of both gastric, duodenal ulcers and relieves the symptoms of ulcers. Provides anti-erosive protection to hydrochloric acid-induced erosion. (Cecilia P Turssi, 2019) A valuable drug in the treatment of NSAID-induced lesions in the upper gastrointestinal tract. (May, 1989) Offers a promising therapy to patients with unsatisfactory responses to proton pump inhibitors alone. (Takuya Hayakawa, 2019) Represents an effective and safe treatment for duodenal ulcers. (L Elsborg, 1984) Attains a healing rate of about 79% for duodenal ulcers in 4 weeks as of cimetidine and ranitidine. (Lam, 1991)

A powerful digestive supplement and group of B-vitamins treat digestive disorders. Promotes the digestion of starch, carbohydrates, fats, and proteins found in ingested food. Significantly accelerates the rate of digestion and helps to restore the loss of appetite. Eases digestive symptoms such as acid indigestion, flatulence, epigastric distress, burping dyspepsia, and heartburn. Aids in proper digestion by accelerating the digestion process and gastric problems in the body. Assists in boosting the immune system, and prevents vitamin deficiency due to poor diet, chronic illness. A beneficial digestive aid for loss of appetite due to chronic illness, stomach fullness, and indigestion. Protects the mucous membranes in the digestive system. Helps maintain a healthy digestive system and regulates appetite.

A pain reliever medicine that is used for the short-term treatment of pain, especially post-operative pain and fever. A well-known, first-line, effective antipyretic and analgesic agent. (Elizabeth Chiam, 2015) Prevents the release of certain chemical messengers that cause pain and fever. Provides a rapid decline in body temperature. (D H Kett, 2011) Has a faster onset of action, greater analgesic efficacy, and a longer duration of action. An effective analgesic that is useful in a broad range of clinical conditions. (Chhaya V Sharma, 2014) Possesses similar analgesic properties as dexketoprofen in migraine and musculoskeletal trauma treatment.(Atakan Yilmaz, 2019), (Ibrahim Turkcuer, 2014) The best pain relief therapy in postoperative settings. (Keith A Candiotti, 2010) Offers satisfactory analgesia and reduces the consumption of opioids. (Uppal, 2011) A first-line agent for the treatment of pain and fever in adults and children. (Sean T Duggan, 2009) A well-tolerated drug that offers rapid and effective analgesia in patients with moderate to severe pain after orthopedic surgery. (Raymond S Sinatra, 2005) A suitable alternative to IV tramadol for postoperative pain relief in cesarean section.(Kumari Usha Rani, 2016)

An antiparasitic drug that is used in the treatment and management of scabies and pediculosis. (Nanda & Juergens, 2021) A potent insecticide that is very effective against mites, lice, ticks, and fleas on the scalp and the skin. A potential drug that kills the mites and their eggs and cures the infection. The drug of choice for the treatment of scabies. The first-line treatment of scabies in patients older than 2 months of age. (Lina Albakri, 2010) A very effective agent against a large variety of insects and mites. (Haustein, 1991) Offers a rapid onset of action than ivermectin in patients with scabies. (Reena Sharma, 2011) More effective in reducing skin irritation than crotamiton and lindane. (Lina Albakri, 2010) A valuable agent in treating scabies and pediculosis. (Japbani Nanda)

Belongs to the therapeutic class of antacid and anti-reflux that helps in the relief of acid-related indigestion, and heartburn. A safe and effective drug for the initial treatment and maintenance therapy for the management of erosive and non-erosive GERD. (Sony Mathews, 2010) A highly effective agent with a good safety profile for long-term prophylaxis of reflux esophagitis. (J Mössner, 1997) Provides rapid relief from heartburn, acid regurgitation, and pain in swallowing in reflux esophagitis individuals. (R Corinaldesi, 1995) Demonstrates excellent effectiveness in the control of symptoms of both functional dyspepsia and non-erosive reflux disease. (R Lozano, 2007) Quickens gastric and gall bladder emptying improves gastrointestinal symptoms. (Ratnani IJ, 2015) Displays efficacy in the management of dyspeptic symptoms in comparison to antisecretory agents (cimetidine, ranitidine) and prokinetic agents (metaclopramide, domperidone). (Ratnani IJ, 2015)

An oral solution for the treatment of constipation as well as complications of liver disease. An osmotic laxative that increases the water content of stools, and promotes colonic peristalsis. (Mohammad Salem Shatnawi, 2019) Stimulates the growth of health-promoting bacteria in the human gut. (Tarkan Karakan, 2021) Produces a statistically significant increase in the frequency, weight, volume, and water content of stools, inducing evacuation of feces in people with constipation. (P Bass, 1981) The first-line treatment for hepatic encephalopathy. (Lise Lotte Gluud, 2016) Decreases the intestinal production and absorption of ammonia in hepatic encephalopathy patients. (Samiran Mukherjee, 2021) Improves cognitive function and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy. (Srinivasa Prasad, 2007) A potential therapeutic agent for the management of subacute clinical encephalopathy. An effective regimen for the prevention of recurrence of hepatic encephalopathy in patients with cirrhosis. (Sharma, Sharma, Agarwal, & Sarin, 2009)

A combination of dietary supplements replenishes the body's reserves of essential nutrients. An efficient oral iron supplement in the treatment of iron deficiency anemia in the pediatric age group compared to colloidal iron. (Diksha Asati, 2021) Helps the body to make healthy new blood cells and boosts hemoglobin levels. Effectively treats iron deficiency-related hemoglobin disorders. Shows a beneficial effect on pregnancy outcomes like gestational age and birth weight. (Rashmi Fadnavis, 2011) Significantly boost up the hemoglobin levels with iron deficiency anemia as a comparison to colloidal iron. (Vijay N Yewale, 2013) An effective therapeutic choice for the prevention of pregnancy complications. (Azar Danesh Shahraki, 2016) The most commonly prescribed oral hematinic has 52% higher absorption than ferrous sulphate in patients having iron deficiency. (Moumita Hazra, 2019) Ferrous ascorbate (1.13 gm%) is more effective than ferrous sulphate (0.93 gm%) in rising hemoglobin in the treatment of iron deficiency anemia in pregnancy. (Savita Rani Singhal, 2015) An essential nutrient from the B complex group of vitamins and plays a crucial role in the production of red blood cells in the body. (J G Donnelly, 2001) Reduces a woman's risk of having a child with brain or spinal cord defects. (Azar Danesh Shahraki, 2016)

A broad-spectrum antibiotic effective against both gram-positive and gram-negative bacteria. A promising candidate for the therapy of urinary tract infections. (Demetra Kavatha, 2003) An effective and safe drug for the treatment of acute uncomplicated lower urinary tract infections. (Demetra Kavatha H. G., 2003) A useful alternative to fluoroquinolones for the treatment of cystitis with its broad spectrum of antimicrobial activity. (Thomas M. Hooton, 2013) More effective than phenoxymethyl-penicillin in the treatment of pharyngotonsillitis. (J A Balfour, 1996) A profitable addition to the antibacterial available for the treatment of infections of the lower respiratory tract. (A M Geddes, 1991) An effective alternative to established beta-lactam therapies for the treatment of infections of the respiratory and urinary tracts as well as those of the skin and soft tissues. (J E Frampton, 1992)

A broad-spectrum cephalosporin antibiotic is used for the treatment of several bacterial infections. (Ming-Jen Sheu, 2020) Produces significant synergistic antibacterial activity against gram-negative bacteria. (Xiao-Xia Wang, 2021) Possesses stronger antibacterial potency than cefoperazone alone against E. coli. (S Iwata, 1984) An effective and safe drug for respiratory tract infections caused by beta-lactamase-producing as well as beta-lactamase non-producing bacteria. (H Koga, 1996) Shows high efficacy in the treatment of severe nosocomial infections and infectious endocarditis. (N V Beloborodova, 2005) As effective as piperacillin-tazobactam in the management of adult patients with hospital-acquired pneumonia and ventilator-associated pneumonia. (Chia-Hung Chen, 2021) A very useful drug in the treatment of lower respiratory tract infections. (T Ishibashi, 1990) An effective antibiotic for the treatment of severe infections in the presence of concurrent hematologic diseases. (A Horiuchi, 1989) A cheaper alternative to meropenem against gram-negative bacilli. (N Poudyal, 2012) A therapeutic option for the treatment of patients with febrile neutropenia. (Shao-Huan Lan, 2020)

A nutritional supplement that prevents or treats conditions caused by low blood calcium levels. (Fritz, Taylor, & Parmar., 2021) A valuable agent in treating osteoporosis, hypothyroidism, rheumatoid arthritis, and many other disorders that lower serum calcium levels. (Fritz, Taylor, & Parmar., 2021) An important therapy for the development, growth, and maintenance of a healthy skeleton. (Holick, 2003) Effective in preventing further deterioration in bone quality and reducing fracture rates. (Diamond, 2008) Improves bone quality, increases bone strength, and prevents fractures and falls. (Mayumi Sakuma, 2008) A well-tolerated medication and is effective for treating vitamin D deficiency. (Diamond, 2008) Ameliorates bone mineral density and reduces fracture risk in individuals with vitamin D deficiency. (Diamond, 2008) Helps in producing new blood cells and prevents low folate levels. A promising treatment strategy that targets both bone mineral density, as well as muscle strength, and the risk of falling. (H A Bischoff-Ferrari, 2003) A beneficial agent for optimal musculoskeletal health, promotes calcium absorption, and maintenance of muscle function. (Pang Yao, 2019)

A pain-reliever medication that treats acute painful musculoskeletal disorders. Stops the release of certain chemical messengers responsible for pain and muscle stiffness. Provides a moderately strong relaxing action and produces lesser side effects than other muscle relaxers. (Steuer) Relaxes muscles and alleviates pain caused by strains, sprains, and other musculoskeletal conditions. (Chintan R Patel, 2012) Exhibits potent anti-inflammatory, analgesic, and antipyretic actions. (Shukla AK, 2015) Exerts a substantially greater analgesic effect than indomethacin, naproxen, or several other NSAIDs. (Shukla AK, 2015)

A benzamide derivative that improves food movement and treats disorders of the stomach and intestines.(Fermı́n Mearin, 2004) Possesses antipsychotic, gastrointestinal motor, and antiemetic activities.(Fermı́n Mearin, 2004) Accelerates gastric emptying and reduces discomfort in response to gastric distention. (Fermı́n Mearin, 2004) A useful therapeutic option in the management of patients with functional dyspepsia, as well as in those with delayed gastric emptying. (Jordi Serra, 2010) A prokinetic drug that is used for gastric motility disorders. (Dr. Jacob Joe, 2020) Has mood-elevating properties that treat psychosis such as schizophrenia, anxiety disorders, vertigo, and peptic ulceration. (Dr. Jacob Joe, 2020) Significantly more effective in controlling chemotherapy-induced nausea, vomiting, and dyspeptic symptoms compared to metoclopramide, domperidone. (Chi-Wook Song, 1998) Improves dyspeptic symptoms and decreases the dyspepsia total symptom score in patients with functional dyspepsia. (Fermı́n Mearin, 2004)

A combination of anti-asthma and anti-allergic drugs prevents asthma and relieves symptoms like sneezing, runny nose, and allergic skin due to various allergies. Has a rapid onset of action which relieves allergy symptoms like runny nose, watery eyes, and sneezing. Has better efficacy than desloratadine, loratadine, or fexofenadine in the management of allergic rhinitis and skin allergies. (NB Dhanya, 2008) Produces a significant decrease in sneezing, rhinorrhea, itching nose, itching eyes, and nasal congestion. (E Nettis, 2009) Induces a more substantial reduction of histamine wheal in a higher percentage of patients for a longer time than desloratadine. (E Nettis, 2009) An effective drug for treating chronic asthma, reduces inflammation in the airways and nose and improves symptoms. Promotes mucous clearance, facilitates expectoration, and eases productive cough. (Mario Malerba, 2008) Produces clinically relevant improvements in asthma-related parameters, including symptoms, lung function parameters, quality of life, and the number of asthma exacerbations. (Zuzana Diamant, 2009) An effective prophylactic agent for asthma and relieves symptoms of seasonal allergies. Has a dual mechanism of action and acts both as a bronchodilator and anti-inflammatory agent. (Mohini Sachin Mahatme, 2016) Decreases the sputum's thickness, making it easier to cough out. An efficacious secretolytic therapy for patients with acute and chronic respiratory diseases. (Ahmad Kantar, 2020)

A combination of penicillin-class antibacterial and beta-lactamase inhibitor that treats a wide variety of bacterial infections by stopping the growth of bacteria. A potent broad spectrum of antibacterial activity against aerobic and anaerobic, including beta-lactamase-producing pathogens. Anthony R White, 2004) The first-line therapy for uncomplicated acute otitis media, sinusitis, and pneumonia because of its activity against Streptococcus pneumoniae and Haemophilus influenza. (Klein, 2003) Exerts high bacteriological and clinical efficacy in respiratory tract infection over more than 20 years. (Anthony R White C. K., 2004) Eradicates or suppresses all penicillin-susceptible and penicillin-intermediate Streptococcus pneumoniae and 73% of penicillin-resistant Streptococcus pneumoniae. (Klein J. O., 2003) An effective drug for a variety of pediatric infectious diseases, including acute otitis media, sinusitis, pneumonia, urinary tract infections, and infections of the skin and soft tissues. (Klein J. O., 2003) Has comparable efficacy to cefaclor for treating uncomplicated urinary tract infections, acute bronchitis and bronchopneumonia, acute sinusitis, otitis media, and skin and soft-tissue infections. (G E Stein, 1984)

A combination drug that provides relief from painful inflammatory diseases. Blocks the production of certain body chemicals which causes pain and swelling in the injured or damaged tissue. A valuable approach for acute and chronic pain associated with inflammatory conditions, especially those involving the musculoskeletal system. (Alfaro & Davis.) A promising approach for the management of mild to moderate pain and inflammation. A fast-acting analgesic and useful for patients who are required immediate relief from inflammatory pain. (Giath Gazal, 2017) Exerts remarkable anti-inflammatory, anti-edemic, and analgesic effects in various areas, including surgery, orthopedics, otorhinolaryngology, gynecology, and dentistry. (Swati B. Jadhav, 2020) An effective analgesic, anti-inflammatory agent that provides symptomatic relief in a variety of painful conditions. Reduces the pain intensity and improves functional ability. A beneficial medication that decreases the swelling around the infected area. Lessens the pain in musculoskeletal disorders with better patient compliance and tolerability.

A proton pump inhibitor and a prokinetic agent that helps in treating acidity-related problems. Improves gastroesophageal reflux disease symptoms and indigestion. Lessens the amount of acid in the stomach and diminishes the symptoms of nausea and vomiting. Provides greater acid control in subjects with symptoms of gastro-oesophageal reflux disorder. (Kerstin Röhss, 2004) Promotes the motility of the upper gastrointestinal tract to prevent nausea or vomiting. A promising therapeutic agent that improves the management of patients with gastroesophageal reflux disease. (Mingxing Hou, 2020) Effectively maintains intragastric pH greater than 4 for a longer period than lansoprazole 30 mg, omeprazole 20 mg, pantoprazole 40 mg and rabeprazole 20 mg GERD patients. (Kerstin Röhss, 2004) Provides significantly more effective and more sustained gastric acid control than lansoprazole 30 mg or rabeprazole 20 mg. (Clive H Wilder-Smith, 2003) More effective than omeprazole in healing and symptom resolution in GERD patients with reflux esophagitis.

An amalgamation of natural extracts relieves the painful symptoms of excessive gas in the stomach and intestines. A combination of an anti-foaming agent, an antiflatulent, and a carminative agent that disintegrates the gas bubbles and expels the gas. A medication used in the management and treatment of flatulence and indigestion. Possesses anti-spasmodic qualities that reduce the symptoms of colic in infants and children. Relieves the pressure caused by excess gas in the stomach and intestines. Relaxes the muscles in the gastrointestinal system and relieves abdominal cramps and pain. Eases flatulence and provides relief from an upset stomach. Lessens intestinal spasms and increases the motility of the small intestine. (Irina Alexandrovich, 2003) A valuable agent that encourages bowel movements and the elimination of gases.

A combination of laxatives and stool lubricant relieves constipation by preventing dry and hard stools. Effectively treats constipation associated with piles, fissures, hernia, and pre and post-operative conditions. An osmotic laxative that increases water in the intestines induces defecation. (Morris Gordon, 2016)Lessens the pain caused by anorectal diseases like piles, fistula, or fissure, thereby providing relief from constipation. Demonstrates a significant increase in the frequency of bowel movements, decrease in the frequency of incontinence episodes, and resolution of abdominal pain. (Vera Loening-Baucke, 2006) Raises the osmotic pressure in the intestinal tract, increasing the water content and volume of the stool. A beneficial agent for the long-term treatment of constipation and fecal incontinence. A well-tolerated and effective medication in the treatment of chronic constipation. (Susanne Kienzle-Horn, 2007) Stimulates peristaltic action, increases water and electrolyte secretion, and facilitates the evacuation of the stools. (Morris Gordon, 2016) A highly effective medicine that assists in causing movement of the intestines.

A non-drowsy antihistamine medicine for the treatment of seasonal allergic rhinitis, and chronic idiopathic urticaria. (Craun & Schury.) A safe and non-sedating medication that effectively reduces all seasonal allergic rhinitis symptoms in children aged 6-11 years. (Eli O Meltzer, 2004) Blocks the effects of histamine that is responsible for allergy. Shows statistically significant improvement in symptoms such as blocked nose, sneezing, rhinorrhea, itchy nose/palate and/or throat, and itchy/watery/red eyes in pediatric patients with allergic rhinitis. (J Ngamphaiboon, 2005) Effectively treats moderate to severe seasonal allergic rhinitis symptoms. Less likely to cause drowsiness as compared to some older antihistamines. Displays a favorable safety profile and results in greater treatment satisfaction in children compared with other second-generation antihistamines. (Eli O. Meltzer, 2021)

An oral solution for the treatment of constipation as well as complications of liver disease. An osmotic laxative that increases the water content of stools, and promotes colonic peristalsis. (Mohammad Salem Shatnawi, 2019) Stimulates the growth of health-promoting bacteria in the human gut. (Tarkan Karakan, 2021) Produces a statistically significant increase in the frequency, weight, volume, and water content of stools, inducing evacuation of feces in people with constipation. (P Bass, 1981) The first-line treatment for hepatic encephalopathy. (Lise Lotte Gluud, 2016) Decreases the intestinal production and absorption of ammonia in hepatic encephalopathy patients. (Samiran Mukherjee, 2021) Improves cognitive function and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy. (Srinivasa Prasad, 2007) A potential therapeutic agent for the management of subacute clinical encephalopathy. An effective regimen for the prevention of recurrence of hepatic encephalopathy in patients with cirrhosis. (Sharma, Sharma, Agarwal, & Sarin, 2009)

An oral solution for the treatment of constipation as well as complications of liver disease. An osmotic laxative that increases the water content of stools, and promotes colonic peristalsis. (Mohammad Salem Shatnawi, 2019) Stimulates the growth of health-promoting bacteria in the human gut. (Tarkan Karakan, 2021) Produces a statistically significant increase in the frequency, weight, volume, and water content of stools, inducing evacuation of feces in people with constipation. (P Bass, 1981) The first-line treatment for hepatic encephalopathy. (Lise Lotte Gluud, 2016) Decreases the intestinal production and absorption of ammonia in hepatic encephalopathy patients. (Samiran Mukherjee, 2021) Improves cognitive function and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy. (Srinivasa Prasad, 2007) A potential therapeutic agent for the management of subacute clinical encephalopathy. An effective regimen for the prevention of recurrence of hepatic encephalopathy in patients with cirrhosis. (Sharma, Sharma, Agarwal, & Sarin, 2009)

An effective remedy that treats respiratory conditions, particularly those associated with excessive mucus production and airway constriction. Improves breathing, reduces coughing, and clears mucus from the airways. Eases the discomfort caused by the excessive build-up of mucus in the respiratory tract. (JeanClare Seagrave, 2011) Significantly reduces mucus viscosity and adhesiveness from the respiratory tract. (Pozzi E. , 2007) A valuable medication that is effective in regulating airway mucus and decreases inflammation in respiratory conditions. (Pozzi E. , 2007) Dilates the bronchial airways, reduces airway inflammation and promotes the removal of mucus. (Pozzi E. , 2007) Possesses anti-inflammatory properties that help in clearing the inflammation of the lung airways. (Ajitha Sharma, 2014) Enhances ciliary clearance, reduces bronchial obstruction episodes, and improves ventilatory function measures. (Ajitha Sharma, 2014) Assists in reducing congestion and improving breathing in individuals dealing with excessive mucus production in their airways. (JeanClare Seagrave, 2011) Provides quick relief from bronchospasm (constriction of the airways) in conditions like asthma. Relieves symptoms of respiratory conditions, such as cough, congestion, and sputum adhesiveness. (Helmut H. Albrecht, 2017)

A powerful digestive supplement and group of B-vitamins treat digestive disorders. Promotes the digestion of starch, carbohydrates, fats, and proteins found in ingested food. Significantly accelerates the rate of digestion and helps to restore the loss of appetite. Eases digestive symptoms such as acid indigestion, flatulence, epigastric distress, burping dyspepsia, and heartburn. Aids in proper digestion by accelerating the digestion process and gastric problems in the body. Assists in boosting the immune system, and prevents vitamin deficiency due to poor diet, chronic illness. A beneficial digestive aid for loss of appetite due to chronic illness, stomach fullness, and indigestion. Protects the mucous membranes in the digestive system. Helps maintain a healthy digestive system and regulates appetite.

A combination of penicillin-class antibacterial and beta-lactamase inhibitors that treats a wide variety of bacterial infections by stopping the growth of bacteria. A potent broad spectrum of antibacterial activity against aerobic and anaerobic, including beta-lactamase-producing pathogens. (Anthony R White, 2004) The first-line therapy for uncomplicated acute otitis media, sinusitis, and pneumonia because of its activity against Streptococcus pneumoniae and Haemophilus influenza. (Klein, 2003) Exerts high bacteriological and clinical efficacy in respiratory tract infection over more than 20 years. (Anthony R White C. K., 2004) Eradicates or suppresses all penicillin-susceptible and penicillin-intermediate Streptococcus pneumoniae and 73% of penicillin-resistant Streptococcus pneumoniae. (Klein J. O., 2003) An effective drug for a variety of pediatric infectious diseases, including acute otitis media, sinusitis, pneumonia, urinary tract infections, and infections of the skin and soft tissues. (Klein J. O., 2003) Has comparable efficacy to cefaclor for treating uncomplicated urinary tract infections, acute bronchitis, bronchopneumonia, acute sinusitis, otitis media, and skin and soft-tissue infections. (G E Stein, 1984)